Viral Vector Manufacturing Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Viral Vector Manufacturing Market place for the forecast 2020– 2025.
Get Sample Report: @ https://brandessenceresearch.com/requestSample/PostId/666
Scope of The Report:
the characteristics of viral vectors such as non-pathogenic nature and capability of expressing therapeutic genes efficiently fuels the development of the viral vector manufacturing market.
Gene therapy is one of the favored treatment alternatives for most chronic diseases, comprising insertion of an operational copy of a gene into a faulty cell. Viral vector techniques are employed in effectual transfer of therapeutic gene into the desired cells. Viral vectors employed in gene therapy comprise adenoviral vectors, retroviral vectors, and adeno-associated viral vectors.
The global viral vector manufacturing market has been divided into disease, type, end-user, and application. The market, by type, has been divided into adeno-associated viral vectors, adenoviral vectors, retroviral vectors, and other viral vectors. The market, by retroviral vectors, has been further divided into gamma-retroviral vectors and lentiviral vectors. The market, by disease, has been divided into infectious diseases, genetic disorders, cancer, and others. The market, by application, has been divided into vaccinology and gene therapy. The market, by end-user, has been divided into research institutes, pharmaceutical and biotechnology companies, and others. The market has been divided, by region, into the Europe, Americas, the Middle East & Africa, and Asia-Pacific. The American viral vector manufacturing market has further been divided into South America and North America, with the market in North America segmented into Canada and the US.
Viral Vector Manufacturing Key Players
The major players included in the global viral vector manufacturing market forecast are,
- Sanofi
- FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- Merck KGaA
- Lonza
- Oxford BioMedica
- GENERAL ELECTRIC COMPANY
- uniQure N.V.
- Spark Therapeutics, Inc.
- Brammer Bio
- FinVector Vision Therapies
- Cobra Biologics
- Cell and Gene Therapy Catapult
- Kaneka Eurogentec S.A.
- REGENXBIO Inc.
Key Market Segments:
By Type: Retroviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, Other
By Disease: Cancers, Genetic Disorders, Infectious diseases, Other
By Application: Gene Therapy, Vaccinology
By End User: Pharmaceutical and Biopharmaceutical Companies, Research Institutes
Increase In Number Of Clinical Tests Predicted To Power The Development Of The Viral Vector Manufacturing Market
Various factors such as increase in number of clinical tests, rise in the number of gene therapy candidates, and increasing necessity for an effective mode of disease cure are predicted to power the development of the market. In addition to this, the characteristics of viral vectors such as non-pathogenic nature and capability of expressing therapeutic genes efficiently fuels the development of the market. In addition to this, several firms comprised in the growth of viral agent-based goods often seek support in terms of tactical acquisitions and collaborations with contract service suppliers to offer a clinical grade product. This is majorly owing to the complexity and restricted availability of platform and techs employed for vector production, designing, release testing, and packaging. For instance, Merck in December 2017 declared a commercial supply deal to make viral vectors for Bluebird Bio, Inc. for its employment in possibly transformative gene treatments. This decision will emphasize the life science business of Merck as a top contract making agency and commercial supplier of viral vectors for gene treatment.
Americas Is Predicted To Lead The Global Viral Vector Manufacturing Market
Regionally, the Americas is predicted to lead the global viral vector manufacturing market due to rising occurrence of chronic and autoimmune diseases and a well-developed healthcare industry. As per a study posted by PFCD (Partnership to Fight Chronic Disease) in 2016, 191 million individuals in America had minimum 1 chronic disease, whereas 75 million had more than 2 chronic diseases in 2015.
Europe is predicted to have the second biggest position in the global market for viral vector manufacturing. The market development in this area is credited to the accessibility of funds for research and rising healthcare expenditure. As per the European Commission, the total expenditure of the governments in 2016 of the European Union on health totaled to 7.1% of GDP. Moreover, as per NIHR (National Institute of Health Funding), a funding of Euro 928 million in 2016 was declared for new NIHR CRF (Clinical Research Facilities) and NIHR BRC (Biomedical Research Centres) for 5 years.
Market by Regional Analysis
North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa
Get Full Report: @ https://brandessenceresearch.com/healthcare/viral-vector-manufacturing-market-size
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com
Media Contact
Company Name: Brandessence Market Research and Consulting Pvt ltd.
Contact Person: Alan
Email: Send Email
Phone: +917447409162
Address:Office No 101 City Point, Survey No. 171/9, Bhekrai Nagar, Near HP Petrol Pump, Opp. HDFC bank Hadapsar-Saswad Road
City: Pune
State: Maharashtra
Country: India
Website: https://brandessenceresearch.com/